Skip to main content
LMRI
NASDAQ Industrial Applications And Services

Lumexa Imaging Reports Q2 Profitability, Strong Operating Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$12.295
Mkt Cap
$1.181B
52W Low
$6.45
52W High
$19.45
52W Position info
91% above low
Off High info
37% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

LMRI sits 91% above its 52-week low of $6.45.

Summary

Lumexa Imaging Holdings, Inc. reported a significant financial turnaround in Q2 2026, achieving net profitability and strong positive operating cash flow, driven by reduced interest expenses from recent debt refinancing.


Key Events · Earnings and Guidance · LMRI

  • Return to Profitability

    The company achieved net income of $2.7 million in Q2 2026, a significant improvement from a $7.2 million loss in Q2 2025. Year-to-date net income was $4.4 million, reversing a $14.9 million loss from the prior year.

  • Strong Operating Cash Flow

    Generated $35.7 million in net cash from operating activities year-to-date, a substantial improvement from using $11.9 million in the prior year, primarily due to reduced interest payments.

  • Debt Repricing

    Successfully repriced its $825 million Refinancing Term Loan on June 30, 2026, reducing the interest rate from SOFR plus 3.0% to SOFR plus 2.5%, which will further decrease future interest expenses.

  • Ongoing Internal Control Weaknesses

    Management continues to report material weaknesses in internal control over financial reporting, indicating ongoing challenges in financial reporting processes.


Analysis · LMRI · Industrial Applications And Services

Lumexa Imaging Holdings, Inc. has achieved a significant financial turnaround, moving from net losses to profitability and generating substantial positive operating cash flow. This improvement is largely due to reduced interest expenses following recent debt refinancing and a subsequent interest rate reduction. While these financial results are positive, the company continues to face challenges with material weaknesses in internal controls and new litigation stemming from a data breach, which introduce elements of risk.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LMRI was trading at $12.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $6.45 to $19.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LMRI - Latest Insights

LMRI
Nov 12, 2026, 7:31 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $15.95
Real-time Price: $14.76 info
Change: -$1.19 (-7%) info
Market Cap: $1.421B info
LMRI
Nov 10, 2026, 4:08 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.92
Real-time Price: $14.76 info
Change: +$0.840 (+6%) info
Market Cap: $1.421B info
LMRI
Nov 10, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.92
Real-time Price: $14.76 info
Change: +$0.840 (+6%) info
Market Cap: $1.421B info
LMRI
Aug 12, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.00
Real-time Price: $14.76 info
Change: +$2.76 (+23%) info
Market Cap: $1.421B info
LMRI
Aug 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.06
Real-time Price: $14.76 info
Change: +$2.70 (+22%) info
Market Cap: $1.421B info